KNOLL CAPITAL MANAGEMENT, LLC – Eiger BioPharmaceuticals, Inc. Transaction History
KNOLL CAPITAL MANAGEMENT, LLC portfolio value:
$586,000
portfolio value
KNOLL CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+19.52%
quarter
Eiger BioPharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -15.60% | -108.26K shares | -3.78M | $7.53 | 585.96K |
Q2 2022 | share | 0.00% | 0 shares | -1.38M | $6.3 | 694.23K | |
Q1 2022 | share | 0.00% | 0 shares | 2.15M | $8.3 | 694.23K | |
Q4 2021 | share | 0.00% | 0 shares | -1.03M | $5.21 | 694.23K | |
Q3 2021 | share | 0.00% | 0 shares | -1.27M | $6.68 | 694.23K | |
Q2 2021 | share | 0.00% | 0 shares | -229K | $8.52 | 694.23K | |
Q1 2021 | share | 0.00% | 0 shares | -2.38M | $8.85 | 694.23K | |
Q4 2020 | share | Increase | +16.63% | 98.99K shares | 3.68M | $12.29 | 694.23K |
Q3 2020 | share | Increase | +13.33% | 70K shares | -218K | $8.14 | 595.23K |
Q2 2020 | share | Increase | +10.52% | 50K shares | 1.83M | $9.6 | 525.23K |
Q1 2020 | share | Increase | +35.69% | 125K shares | -1.98M | $6.8 | 475.23K |
Q4 2019 | share | 0.00% | 0 shares | 1.62M | $14.9 | 350.23K | |
Q3 2019 | share | 0.00% | 0 shares | -123K | $10.25 | 350.23K | |
Q2 2019 | share | Increase | +365.51% | 275K shares | 2.66M | $10.6 | 350.23K |
Q1 2019 | share | 0.00% | 0 shares | 288K | $13.98 | 75.23K | |
Q4 2018 | share | 0.00% | 0 shares | -146K | $10.16 | 75.23K | |
Q3 2018 | share | 0.00% | 0 shares | -8K | $12 | 75.23K | |
Q2 2018 | share | 0.00% | 0 shares | 177K | $12.2 | 75.23K | |
Q1 2018 | share | Increase | 0.00% | 75.23K shares | 741K | $9.85 | 75.23K |